Select Medical Holdings Corporation (NYSE:SEM) Given Average Rating of “Hold” by Analysts

Shares of Select Medical Holdings Corporation (NYSE:SEM) have been assigned a consensus rating of “Hold” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $15.50.

A number of equities analysts recently issued reports on the stock. Weiss Ratings raised shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, June 4th. Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. Mizuho restated a “neutral” rating and issued a $16.50 target price (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 target price (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd.

Select Medical Price Performance

SEM opened at $16.56 on Monday. The stock’s 50 day moving average price is $16.49 and its 200-day moving average price is $15.88. Select Medical has a 52-week low of $11.65 and a 52-week high of $16.99. The stock has a market capitalization of $2.05 billion, a PE ratio of 15.62, a price-to-earnings-growth ratio of 0.95 and a beta of 1.01. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the previous year, the firm posted $0.44 earnings per share. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, equities research analysts predict that Select Medical will post 1.26 EPS for the current year.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s dividend payout ratio is 23.58%.

Institutional Trading of Select Medical

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Quarry LP purchased a new position in Select Medical during the fourth quarter valued at $26,000. Quantbot Technologies LP bought a new position in shares of Select Medical during the third quarter valued at $27,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Select Medical in the 4th quarter worth about $28,000. Hantz Financial Services Inc. boosted its stake in Select Medical by 214.7% in the 4th quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock worth $38,000 after purchasing an additional 1,739 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its position in Select Medical by 37.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 788 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.